ACE2 and COVID-19: In our opinion, the positive significant correlation between the heart and kidney function biomarkers, which were generally more deteriorated in severe COVID-19 patients, and expression levels of receptors ACE2 and NRP-1, may nominate these receptors to be important therapeutic targets in COVID-19 treatment strategies.